| 3.235 0.105 (3.35%) | 09-12 11:34 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 4.43 | 1-year : | 5.01 |
| Resists | First : | 3.79 | Second : | 4.28 |
| Pivot price | 3.28 |
|||
| Supports | First : | 3 | Second : | 2.49 |
| MAs | MA(5) : | 3.13 |
MA(20) : | 3.4  |
| MA(100) : | 4.15 |
MA(250) : | 5 |
|
| MACD | MACD : | -0.2 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 22.5 |
D(3) : | 15.6 |
| RSI | RSI(14): 40 |
|||
| 52-week | High : | 9.1 | Low : | 3 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ LFWD ] has closed above bottom band by 28.6%. Bollinger Bands are 30.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 3.19 - 3.21 | 3.21 - 3.22 |
| Low: | 3.03 - 3.04 | 3.04 - 3.06 |
| Close: | 3.17 - 3.19 | 3.19 - 3.21 |
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.
Thu, 12 Sep 2024
ReWalk Robotics Ltd. Finalizes Corporate Name Change to Lifeward Ltd. - GlobeNewswire
Thu, 12 Sep 2024
ReWalk Robotics Ltd. Finalizes Corporate Name Change to Lifeward Ltd. - StockTitan
Tue, 10 Sep 2024
LFWD - ReWalk Robotics Ltd Latest Stock News & Market Updates - StockTitan
Wed, 14 Aug 2024
ReWalk Robotics (LFWD) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
Sat, 27 Jul 2024
ReWalk Robotics Ltd. (NASDAQ:LFWD): Are Analysts Optimistic? - Simply Wall St
Fri, 26 Jul 2024
ReWalk Robotics Ltd. (LFWD): A Good Robotic Stock Under $10? - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 9 (M) |
| Shares Float | 9 (M) |
| Held by Insiders | 2.7 (%) |
| Held by Institutions | 21.6 (%) |
| Shares Short | 196 (K) |
| Shares Short P.Month | 171 (K) |
| EPS | -2.77 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 4.25 |
| Profit Margin | -102.1 % |
| Operating Margin | -66.3 % |
| Return on Assets (ttm) | -23.8 % |
| Return on Equity (ttm) | -49.7 % |
| Qtrly Rev. Growth | 401.6 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 2.65 |
| EBITDA (p.s.) | -2.11 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -25 (M) |
| Levered Free Cash Flow | -14 (M) |
| PE Ratio | -1.15 |
| PEG Ratio | 0 |
| Price to Book value | 0.74 |
| Price to Sales | 1.19 |
| Price to Cash Flow | -1.1 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|